SCHEMBL17403685

SCHEMBL17403685

CCCCC(CC)COc1ccc(-c2cc(Br)c(Br)cc2-c2ccc(OCC(CC)CCCC)c(OCC(CC)CCCC)c2)cc1OCC(CC)CCCC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
MAPK1 P28482 2/20 0.40
CYP3A4 P08684 5/20 0.37
CA2 P00918 1/20 0.37
TSHR P16473 3/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
LMNA P02545 2/20 0.34
HSD17B10 Q99714 1/20 0.34
PRSS1 P07477 1/20 0.33
PRSS2 P07478 1/20 0.33
PRSS3 P35030 1/20 0.33
S1PR1 P21453 2/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
MAPT P10636 1/20 0.33
PTPN11 Q06124 1/20 0.33
TDP1 Q9NUW8 2/20 0.33
ATM Q13315 1/20 0.33
MMP9 P14780 1/20 0.32
MMP8 P22894 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28083440 0.84 CYP3A4 (0.43) ALDH1A1MAPK1CYP3A4CA2TSHR
SCHEMBL1777917 0.82 ALDH1A1 (0.43) ALDH1A1MAPK1CYP3A4CA2TSHR
Ethyne SCHEMBL28554272 0.81 ALDH1A1 (0.40) ALDH1A1MAPK1CYP3A4CA2TSHR
SCHEMBL17403688 0.80 CYP3A4 (0.40) ALDH1A1MAPK1CYP3A4CA2TSHR
SCHEMBL2053675 0.78 CYP3A4 (0.43) ALDH1A1MAPK1CYP3A4CA2TSHR
SCHEMBL4382238 0.78 ALDH1A1 (0.42) ALDH1A1MAPK1CYP3A4CA2TSHR
SCHEMBL25953068 0.78 ALDH1A1 (0.43) ALDH1A1MAPK1CYP3A4CA2TSHR
SCHEMBL6251007 0.77 ALDH1A1 (0.41) ALDH1A1MAPK1CYP3A4CA2TSHR
SCHEMBL28029056 0.77 ALDH1A1 (0.42) ALDH1A1MAPK1CYP3A4CA2TSHR
SCHEMBL16432304 0.76 CYP3A4 (0.39) ALDH1A1MAPK1CYP3A4CA2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9403825-B2 Compound, solar cell module, and photovoltaic power generation device SHARP KABUSHIKI KAISHA (JP) 2016-08-02 US disclosed
US-9403825-B2 Compound, solar cell module, and photovoltaic power generation device SHARP KABUSHIKI KAISHA (JP) 2016-08-02 US disclosed
US-20160002238-A1 COMPOUND, SOLAR CELL MODULE, AND PHOTOVOLTAIC POWER GENERATION DEVICE SHARP KABUSHIKI KAISHA (JP) 2016-01-07 US disclosed
US-20160002238-A1 COMPOUND, SOLAR CELL MODULE, AND PHOTOVOLTAIC POWER GENERATION DEVICE SHARP KABUSHIKI KAISHA (JP) 2016-01-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160002238-A1 COMPOUND, SOLAR CELL MODULE, AND PHOTOVOLTAIC POWER GENERATION DEVICE CRY1, CCNE2, CCND2 ALDH1A1 1433/4885MAPK1 747/4885CYP3A4 1714/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.